Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.5    
    

 
  STOCK OPTION GRANT PROGRAM
  FOR
  NONEMPLOYEE DIRECTORS UNDER THE
  PONIARD PHARMACEUTICALS, INC.
  2004 INCENTIVE COMPENSATION PLAN
  (as amended June 15, 2005,
September 27, 2006, February 7, 2007 and June 14, 2007)    
    

        The following provisions set forth the terms of the stock option grant program (the "Program") for nonemployee directors of Poniard Pharmaceuticals, Inc.
(the "Company") under the Company's 2004 Incentive Compensation Plan (the "Plan"). The following terms are intended to supplement, not alter or change, the provisions of the Plan, and in the event of
any inconsistency between the terms contained herein and in the Plan, the Plan shall govern. All capitalized terms that are not defined herein shall be as defined in the Plan. 

	1.
	Eligibility

        Each
director of the Company elected or appointed to the Board who is not otherwise an employee of the Company or any Related Corporation (an "Eligible Director") shall be eligible to
receive New Grants and Annual Grants under the Plan, as discussed below. 

	2.
	New Grants

        Each
Eligible Director shall receive a nonqualified stock option to purchase 30,000 shares of Common Stock ("New Grant") upon such Eligible Director's initial election or appointment to
the Board. New Grants shall vest and become exercisable in two equal installments according to the schedule set forth in Section 4 below. 

	3.
	Annual Grants

        Beginning
with the 2007 annual meeting of shareholders, each Eligible Director shall automatically receive a nonqualified stock option to purchase 15,000 shares of Common Stock
immediately following each year's annual meeting of shareholders (each, an "Annual Grant"); provided that any Eligible Director who received a New Grant within five months prior to an annual meeting
of shareholders shall not receive an Annual Grant until the next year's annual meeting. Annual Grants shall vest and become exercisable in two equal installments according to the schedule set forth in
Section 4. 

	4.
	Vesting and Exercisability

        Options
shall vest and become exercisable according to the following schedule: 

	(a)
	New Grants

	Period of Optionee's Continuous

Service as a Director From

the Date the Option Is Granted
	 	Portion of Grant

That Is Vested and Exercisable

	One year	 	50%
	

Two years	
 	

100%

	(b)
	Annual Grants

	Period of Optionee's Continuous

Service as a Director From

the Date the Option Is Granted
	 	Portion of Grant

That Is Vested and Exercisable

	Upon first annual meeting of

shareholders after grant	 	50%
	

Upon second annual meeting of

shareholders after grant	
 	

100%

Subject
to the exercisability schedule described above, each option may be exercised in whole or in part at any time; provided, however, that an option may not be exercised for less than a reasonable
number of shares at any one time, as determined by the Plan Administrator. 

 

	5.
	Option Exercise Price

        The
exercise price of an option shall be the fair market value of the Common Stock on the date of grant. 

	6.
	Manner of Option Exercise

        An
option shall be exercised by giving the required notice to the Company, stating the number of shares of Common Stock with respect to which the option is being exercised, accompanied
by payment in full for such Common Stock, which payment may be, to the extent permitted by applicable laws and regulations, in whole or in part (a) in cash or check, (b) in shares of
Common Stock owned by the Eligible Director for at least six months (or any shorter period necessary to avoid a charge to the Company's earnings for financial reporting purposes) having a fair market
value equal to the aggregate option exercise price, or (c) if and so long as the Common Stock is registered under the Exchange Act, by delivery of a properly executed exercise notice, together
with irrevocable instructions to a broker, to promptly deliver to the Company the amount of proceeds to pay the exercise price, all in accordance with the regulations of the Federal Reserve Board. 

	7.
	Term of Options

        Each
option shall expire upon the earlier of ten years from the date of grant or five years after an Eligible Director's termination of service as a director, as follows: 

        (a)   In
the event that an Eligible Director ceases to be a director of the Company for any reason other than the death of the Eligible Director, the unvested portion of any
option granted to such Eligible Director shall terminate immediately and the vested portion of the option may be exercised by the Eligible Director only within five years after the date he or she
ceases to be a director of the Company or prior to the date on which the option expires by its terms, whichever is earlier. 

        (b)   In
the event of the death of an Eligible Director, the unvested portion of any option granted to such Eligible Director shall terminate immediately and the vested
portion of the Option may be exercised only within five years after the date the Eligible Director ceases to be a director or prior to the date on which the option expires by its terms, whichever is
earlier, by the personal representative of the Eligible Director's estate, the person(s) to whom the Eligible Director's rights under the option have passed by will or the applicable laws of descent
and distribution or the beneficiary designated pursuant to Section 12 of the Plan. 

	8.
	Transferability

        During
an Eligible Director's lifetime, an option may be exercised only by the Eligible Director or a permitted assignee or transferee of the Eligible Director (as provided below). No
options granted under the Program may be sold, assigned, pledged or transferred by the Eligible Director or made subject to attachment or similar proceedings other than by (a) will or the
applicable laws of descent and distribution, (b) gift or other transfer to either (i) a spouse or other immediate family member or (ii) any trust, partnership or other entity in
which the Eligible Director or such Eligible Director's spouse or other immediate family member has a substantial beneficial interest; or (c) the designation by an Eligible Director in writing
during the Eligible Director's lifetime of a beneficiary to receive and exercise options in the event of the Eligible Director's death (as provided in Section 12 of the Plan); provided,
however, that any option so assigned or transferred shall be subject to the terms and conditions of the Plan and the instrument evidencing the option. Any attempt to transfer, assign, pledge,
hypothecate or otherwise dispose of any option under the Plan or of any right or privilege conferred thereby, contrary to the provisions of the Plan, or the sale or levy or any attachment or similar
process upon the rights and privileges conferred hereby, shall be null and void. 

2

 

	9.
	Amendment

        The
Board may amend the provisions contained herein in such respects as it deems advisable. Any such amendment shall not, without the consent of the Eligible Director, impair or diminish
any rights of an Eligible Director under an outstanding option. 

	10.
	Effective Date

        The
Program shall become effective on the date approved by the Company's Board. 

        Provisions
of the Plan (including any amendments) that are not discussed above, to the extent applicable to Eligible Directors, shall continue to govern the terms and conditions of
options granted to Eligible Directors. 

        Effective: May 18, 2004

        Section 2 amended: June 15, 2005

        Sections 2 and 3 amended: September 27, 2006 (to reflect one-for-six reverse
stock split effective September 22, 2006 and to reflect change of company name)

        Sections 2 and 3 amended: February 7, 2007 (to increase "New Grant" to 20,000 shares from 8,333 shares and "Annual Grant" to 10,000 shares from 3,333 shares)

        Sections 2 and 3 amended: June 14, 2007 (to increase "New Grant" to 30,000 shares from 20,000 shares and "Annual Grant" to 15,000 shares from 10,000
shares)

3

QuickLinks

Exhibit 10.5

STOCK OPTION GRANT PROGRAM FOR NONEMPLOYEE DIRECTORS UNDER THE PONIARD PHARMACEUTICALS, INC. 2004 INCENTIVE COMPENSATION PLAN (as amended June 15, 2005, September 27, 2006, February 7, 2007 and June 14,
2007)QuickLinks
 -- Click here to rapidly navigate through this document

 
 

EXHIBIT 10.1    
    

HAEMONETICS CORPORATION  

 2005 LONG-TERM INCENTIVE COMPENSATION PLAN  

 RESTRICTED STOCK AGREEMENT  

 WITH  

 "EMPLOYEE"  

 HAEMONETICS CORPORATION

RESTRICTED STOCK AGREEMENT ("Agreement")

UNDER 2005 LONG-TERM INCENTIVE COMPENSATION PLAN  

        THIS AGREEMENT, dated as of            ("Grant Date") by and between Haemonetics Corporation, a Massachusetts Corporation
("Company"), and                        
("Employee"), is entered into as follows: 

        WHEREAS,
the Company has established the Haemonetics Corporation 2005 Incentive Compensation Plan ("Plan"), a copy of which has been provided to Employee, and which Plan is made a part
hereof; and 

        WHEREAS,
the Compensation Committee of the Board of Directors of the Company ("Committee") determined that the Employee be granted shares of the Company's $0.01 par value Common Stock
("Stock") subject to the terms and conditions as hereinafter set forth; 

        NOW,
THEREFORE, the parties hereby agree as follows: 

1.     Grant of Stock.  

        Subject to the terms and conditions of this Agreement and of the Plan, the Company hereby grants to the
Employee                        of Stock ("Restricted Stock").
 

2.     Vesting Schedule.  

        (a).  The
interest of the Employee in the Stock shall vest as to 25% of such Restricted Stock on the first anniversary of the Grant Date, and as to an additional 25% on each
succeeding anniversary date, so as to be 100% vested on                        , the fourth (4th) anniversary thereof,
conditioned upon the Employee's continued employment with the Company as of
each vesting date. In situations where there is not continued employment, notwithstanding the foregoing, the interest of the Employee in the Stock shall vest as specified below. 

        (b).  Except
as otherwise provided in this Section 2 if the Employee ceases to be an employee of the Company prior to the fourth (4th) anniversary of the Grant Date,
the Restricted Stock granted to the Employee hereunder shall stop vesting on the last date of employment. In such event, vesting shall not be pro-rated between anniversary dates and the
vested amount shall be determined as of the most recent anniversary of the Grant Date. 

        (c).  If
such termination of employment is because the Employee has become disabled as defined in Article 2 of the Plan, such Restricted Stock shall continue to vest. 

        (d).  If
such termination of employment is because the Employee has retired from the Company in good standing then such Restricted Stock shall stop vesting on the last date
of employment. For purposes of this Restricted Stock Agreement, retirement shall mean that the Employee shall have reached age fifty five, and shall have completed at least five years of service with
the Company. Years of service with any of the Company's wholly owned subsidiaries shall be credited as years of service with the Company. 

        (e).  In
the event of the death of the Employee while in the employ of the Company, any unvested Restricted Stock shall immediately become fully vested. 

        (f).   All
of the then unvested Restricted Stock will vest in the event of (i) any sale or conveyance to another entity of all or substantially all of the property and
assets of the Company or (ii) a Change of Control occurs before the Restricted Stock has been vested in full. For purposes hereof a "Change in Control" shall be deemed to have occurred if any
person, or any two or more persons acting as a group, and all affiliates of such person or persons, who prior to such time owned less than thirty-five percent (35%) of the then outstanding
Common Stock of the Company, shall acquire such additional shares of the Company's Common Stock in one or more transactions, or series of transactions, such that following such transaction or
transactions, such person or group and affiliates beneficially own thirty-five percent (35%) or more of the Company's Common Stock outstanding. 

3.     Restrictions.  

        (a)   The
Restricted Stock or rights granted hereunder may not be sold, transferred, pledged, assigned, encumbered, or otherwise alienated or hypothecated until the end of the
applicable Period of Restriction established by the Committee and specified in accordance with Section 2 hereof. The period of time between the date hereof and the date Restricted Stock becomes
vested is referred to herein as the "Period of Restriction". 

        (b)   If
the Employee's employment with the Company is terminated, the balance of the Restricted Stock subject to the provisions of this Agreement which have not vested at the
time of the Employee's termination of employment shall be forfeited by the Employee, and the Company shall have a right to repurchase any unvested Stock from the Employee at a price per share equal to
the Stock par value per share set forth above. The Company's right to so repurchase the Restricted Stock shall be valid for a period of one year beginning on the date of any Termination of Service of
the Employee, or, if the Company is prohibited by law from such repurchase at the time of Termination of Service, for thirty days after any such prohibition is terminated. 

4.     Escrow.  

        All Restricted Stock which has not vested pursuant to Section 2, together with any securities distributed in respect thereof through stock split or other
recapitalization, shall be retained in the Company's
possession until such time as all conditions and/or restrictions applicable to such Stock have been satisfied. The Stock may also be held in a restricted book entry account in the name of the
Employee. The Company shall promptly release vested Stock after the applicable Period of Restriction. 

5.     Employee Shareholder Rights.  

        During the Period of Restriction, the Employee shall have all the rights of a shareholder with respect to the Restricted Stock granted hereunder except for the
right to transfer the Restricted Stock, as set forth in Section 3 and except as set forth in Section 6. Accordingly, the Employee shall have the right to vote the Restricted Stock and to
receive any cash dividends paid to or made with respect to the Restricted Stock. 

6.     Adjustments or Changes in Capitalization.  

        Adjustments or changes in capitalization and the like shall be made in accordance with Article 4 of the Plan, as in effect on the date of this Agreement. 

        In
the event that as a result of (a) any stock dividend, stock split or other change in the Stock, or (b) any merger or sale of all or substantially all of the assets of or
other acquisition of the Company (other than a Change of Control, as defined above), and by virtue of any such change the Employee shall, in his capacity as owner of unvested shares of Restricted
Stock which have been awarded to him (the "Prior Restricted Stock"), be entitled to new or additional or different shares or securities, such new or additional or different shares or securities shall
thereupon be considered to be unvested 

Restricted
Stock and shall be subject to all of the conditions and restrictions which were applicable to the Prior Restricted Stock pursuant to this Agreement. 

7.     Disability termination or permanent and total Disability of Employee.  

        In the event of a termination for Disability or permanent and total Disability of the Employee, any unpaid but vested Restricted Stock shall be paid to the
Employee if legally competent or to a legally designated guardian or representative if the Employee is legally incompetent. 

8.     Taxes.  

        The Employee acknowledges and agrees that any income or other taxes due from the Employee with respect to the Stock issued pursuant to this Agreement, including
on account of the vesting of the Stock, shall be the Employee's responsibility. By accepting this Grant, the Employee agrees and acknowledges that (i) the Company will promptly withhold from
the Employee's pay the amount of taxes the Company is required to withhold upon any vesting of Stock pursuant to this Agreement, and (ii) the Employee shall make immediate payment to the
Company in that amount of any tax required to be withheld by the Company in excess of the Employee's pay available for such withholding. 

9.     Miscellaneous.  

        (a)   The
Company shall not be required (i) to transfer on its books any shares of Stock of the Company which shall have been sold or transferred in violation of any of
the provisions set forth in this Agreement, or (ii) to treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall
have been so transferred. 

        (b)   The
parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Agreement. 

        (c)   Any
notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon delivery to the Employee at his address then on file with
the Company. 

        (d)   Nothing
contained in the Plan or this Agreement shall be construed or deemed by any person under any circumstances to bind the Company to continue the employment of the
Employee during the Period of Restriction. However, during the Employee's employment, the Employee shall render diligently and faithfully the services which are assigned to the Employee from time to
time by the Board of Directors or by the executive officers of the Company and shall at no time take any action which directly or indirectly would be inconsistent with the best interests of the
Company. 

        (e)   This
Agreement and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof. 

HAEMONETICS
CORPORATION 

	
 Brad Nutter, President and CEO	 	 
	

 	
 	

 
	
 Date:	 	 
	

 	
 	

 
	
 ("Employee")	 	 
	

 	
 	

 
	
 Date:	 	 

QuickLinks

EXHIBIT 10.1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]